A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromes
Introduction
Risk-reducing surgery has recently received significant media attention and gained public interest. In 2013, the New York Times published an editorial by Angelina Jolie outlining her own personal experience of risk-reducing surgery for BRCA 1 mutation [1]. Many experts and advocates widely applauded this disclosure, with the aim to benefit other women with strong family histories of breast cancer to get genetic tests [2]. However, others expressed concerns that this could be misinterpreted, fuelling a trend towards preventative surgery that is not medically necessary [2].
Next generation sequencing techniques allow for analysis of many different genes simultaneously, resulting in increased speed, access and lower costs of testing for hereditary cancer syndromes. As a result, and the increased public profile, an increasing number of patients are seeking genetic counselling and undergoing germline mutational testing. Patients with hereditary cancer syndromes may choose several strategies for cancer risk reduction including surgery.
Cancer predisposition genes are rare mutations that confer a high risk of cancer [3] and for many hereditary cancer syndromes, risk-reducing surgery is the single most effective strategy for preventing cancer. This strategy exists for breast (BRCA1&2) [4,5], colon (APC) [[6], [7], [8]], ovary (BRCA1&2) [9], stomach (CDH-1) [10] and thyroid (RET) [6], which all have key cancer predisposition genes [3] and provide an opportunity for risk-reducing surgery. However, risk-reducing surgery is neither feasible nor practical for some hereditary cancer syndromes. For example, patients with PTEN hamartoma tumour syndrome have an estimated 34% lifetime risk of renal malignancy, but a bilateral nephrectomy is an impractical option [11]. This review therefore focuses on hereditary cancer syndromes with feasible risk-reducing surgery options.
An editorial by Professor Brennan emphasises some key issues surrounding risk-reducing surgery for hereditary cancer syndromes such as Familial Adenomatous Polyposis [12]. This highlights the sad reality that many societies have been seduced into believing that living is risk free and demands compensation when accidents, complications and errors occur, even in the absence of malfeasance, summarised as a minatory experience [12]. Professor Brennan further concludes that in an age where technical aspects of operations are sometimes denigrated, a scenario now exists in which technical perfection is to be the norm and society will expect an operative mortality of zero [12]. However, this is a figure that is never uniformly achievable. Given these high expectations for risk-reducing surgery, we sought to systematically review the reported complications for patients undergoing this type of surgery.
Section snippets
Search strategy
A systematic review of published work was conducted as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement for the conduct of a review study [13]. The study team developed a concept table and built a search strategy with a medical librarian to identify articles reporting outcomes from risk-reducing cancer surgery. Two concepts were developed: cancer genes and types of surgery. Exploded medical subject heading (MeSH) terms were combined with text word
Search results
Thirty-four thousand and eighty-nine studies were identified from the literature search of the electronic databases, which, following screening (inclusion/exclusion criteria and removal of duplicates), resulted in 25 full articles for inclusion in this qualitative synthesis (Fig. 1). Among the excluded studies, three were excluded because of duplication of reported outcomes of interest in other publications from the same institution [[15], [16], [17]]. All studies were assessed using the
Discussion
This review highlights the importance of an individualised discussion for patients with cancer predisposition genes considering risk-reducing surgery. Despite the reported outcomes being from many high-volume centres, the morbidity and mortality associated with certain risk-reducing surgery for cancer predisposition genes remains significant. Whilst previously published studies have demonstrated patients are satisfied with the cancer risk reduction, their satisfaction with the surgical outcome
Conflict of interest and source of funding
None.
No sources of support
Short running head: There are high expectations for risk-reducing surgery. A systematic review was performed to evaluate the reported complications for patients undergoing risk-reducing surgery. This study provides an important and necessary summary of the current data, enabling clinicians to better inform patients of the associated short and long-term outcomes in risk-reducing surgery for cancer predisposition genes.
Disclosures
Nil.
Acknowledgements
Nil.
References (51)
- et al.
Hereditary diffuse gastric cancer: prophylactic surgical oncology implications
Surg Clin North Am
(2008) - et al.
Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis
Am J Surg
(1993) - et al.
Assessing the risk of occult cancer and 30-day morbidity in women undergoing risk-reducing surgery: a prospective experience
J Minim Invasive Gynecol
(2017) - et al.
Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers
Maturitas
(2010) - et al.
Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers
Am J Surg
(2017) - et al.
Prophylactic laparoscopic total gastrectomy with jejunal pouch reconstruction in patients carrying a CDH1 germline mutation
J Gastrointest Surg
(2015) - et al.
Pouchitis is a common complication in patients with familial adenomatous polyposis following ileal pouch-anal anastomosis
Clin Gastroenterol Hepatol
(2016) - et al.
Comparison of postoperative outcomes in ulcerative colitis and familial polyposis patients after ileoanal pouch operations
Am J Surg
(2001) My medical choice
(2013)Jolie's disclosure of preventive mastectomy highlights dilemma
(2013)
Realizing the promise of cancer predisposition genes
Nature
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
N Engl J Med
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group
J Clin Oncol
Hereditary cancer predisposition syndromes
J Clin Oncol
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes
Ann Surg Oncol
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes
J Clin Oncol
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation
N Engl J Med
Lifetime cancer risks in individuals with germline PTEN mutations
Clin Cancer Res
Pre-emptive surgery and increasing demands for technical perfection
Br J Surg
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
PLoS Med
The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
The impact of technical factors on outcome of restorative proctocolectomy for familial adenomatous polyposis
Dis Colon Rectum
Laparoscopic total abdominal colectomy with ileorectal anastomosis for familial adenomatous polyposis
Dis Colon Rectum
Total skin-sparing mastectomy in BRCA mutation carriers
Ann Surg Oncol
Outcomes and cost analysis in high-risk patients undergoing simultaneous free flap breast reconstruction and gynecologic procedures
Ann Plast Surg
Cited by (4)
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) – A Helicobacter-opposite point
2021, Best Practice and Research: Clinical GastroenterologyCitation Excerpt :Quality of life after gastric surgery is influenced by the type of operation, principal disease, concomitant therapy, comorbidities, nutritional status, early and late complications, and psychosocial factors. Long-term complications of gastrectomy include diarrhoea, agastric and achylic syndrome, gastric-emptying disorders, early (postprandial) and late dumping syndrome, afferent and efferent loop syndrome, jejunal intussusception, anastomotic complications (ulcer, stenosis), lactase deficiency, protein-energy malnutrition, micronutrients deficiency syndromes, anaemia of combined aetiology, metabolic bone disease, small intestinal bacterial overgrowth syndrome, tuberculosis, secondary protein-losing enteropathy, and acute cholecystitis [84–91]. Advanced adenocarcinoma in GAPPS is associated with poor prognosis.
Young people’s experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management
2022, Journal of Genetic CounselingEvolving Trends in Surgical Management of Breast Cancer: An Analysis of 30 Years of Practice Changing Papers
2021, Frontiers in OncologyProphylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables
2020, United European Gastroenterology Journal